{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:44:50Z","timestamp":1785422690082,"version":"3.56.0"},"reference-count":34,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Victor Babes University of Medicine and Pharmacy, Timisoara"},{"id":[{"id":"https:\/\/ror.org\/00afdp487","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background and Objectives: Severe COVID-19 frequently fulfills Sepsis-3 criteria and is characterized by thrombo-inflammation and endothelial injury. We evaluated whether a bedside endothelial activation index (EAI = D-dimer\/fibrinogen) identifies biologically distinct phenotypes and relates to interleukin-6 (IL-6) response after therapeutic plasma exchange (TPE), and whether baseline IL-6 predicts a \u226550% IL-6 reduction. Methods: Retrospective single-center ICU cohort of adults with SARS-CoV-2 infection, sepsis-related organ dysfunction, and \u22651 TPE session (n = 51). Patients were stratified by median EAI (low vs. high). Outcomes included peri-procedural biomarker\/physiology changes (post\u2013baseline), IL-6 responder status (\u226550% reduction), correlations with IL-6 reduction (%), and multivariable predictors of response. Results: Compared with low EAI (n = 25), high EAI (n = 26) had higher baseline D-dimer (6.2 vs. 2.2 \u00b5g\/mL) and lower fibrinogen (2.9 vs. 7.1 g\/L) (both p &lt; 0.001). Low EAI showed larger CRP decreases (\u0394CRP \u221284.0 vs. \u22122.3 mg\/L; p = 0.001) and larger fibrinogen falls (\u0394 \u22123.1 vs. \u22120.4 g\/L; p &lt; 0.001), while high EAI had larger D-dimer decreases (\u0394 \u22122.5 vs. \u22120.6 \u00b5g\/mL; p = 0.004) and a modest SOFA improvement (\u0394 \u22120.3 vs. +0.1; p = 0.026). IL-6 responders (n = 20) had higher baseline IL-6 than non-responders (365.2 vs. 47.1 pg\/mL; p &lt; 0.001). Baseline IL-6 independently predicted response (per doubling: OR 1.94, 95% CI 1.27\u20132.95; p = 0.002), while age reduced odds (OR 0.91\/year, 95% CI 0.84\u20130.99; p = 0.032). IL-6 reduction correlated with \u0394CRP (\u03c1 = \u22120.41; p = 0.003) and \u0394PaO2\/FiO2 (\u03c1 = 0.37; p = 0.01). Conclusions: EAI stratifies distinct thrombo-inflammatory patterns around TPE, while baseline IL-6 is the dominant predictor of achieving large IL-6 reductions. To emphasize the novelty and clarify the study objective, this exploratory analysis used a phenotype-stratified framework to test whether a simple bedside endothelial activation index could enrich biological response assessment to adjunctive TPE. The prespecified primary outcome was achievement of a \u226550% IL-6 reduction after completion of the TPE course; secondary outcomes included peri-procedural biomarker, oxygenation, SOFA, and ICU endpoints.<\/jats:p>","DOI":"10.3390\/diseases14040123","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:57:11Z","timestamp":1774864631000},"page":"123","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endothelial Activation Phenotypes and Interleukin-6 Response After Therapeutic Plasma Exchange in Severe COVID-19-Associated Sepsis: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Nicoleta","family":"Sgavardea","sequence":"first","affiliation":[{"name":"Doctoral School, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3432-9168","authenticated-orcid":false,"given":"Ovidiu","family":"Bedreag","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care Research Center, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greeshmasree","family":"Kambam","sequence":"additional","affiliation":[{"name":"Frank H. Netter School of Medicine, Quinnipiac University, Hamden, CT 06473, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8302-8003","authenticated-orcid":false,"given":"Tamara Mirela","family":"Porosnicu","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care Research Center, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"G\u00eendac","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care Research Center, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-7241","authenticated-orcid":false,"given":"Claudiu","family":"Barsac","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care Research Center, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Oancea","sequence":"additional","affiliation":[{"name":"Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5188-7479","authenticated-orcid":false,"given":"Patricia","family":"Hogea","sequence":"additional","affiliation":[{"name":"Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6020-4593","authenticated-orcid":false,"given":"Alexandru","family":"Crisan","sequence":"additional","affiliation":[{"name":"Pulmonary Rehabilitation Center, Clinical Hospital of Infectious Diseases and Pulmonology, \u201cVictor Babes\u201d, Gheorghe Adam Street 13, 300310 Timisoara, Romania"},{"name":"Research Center for Assessment of Human Motion, Functionality, and Disability, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voichita Elena","family":"Lazureanu","sequence":"additional","affiliation":[{"name":"Discipline of Infectious Disease, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: A meta-analysis","volume":"92","author":"Aziz","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet, 397, 1637\u20131645.","DOI":"10.1101\/2021.02.11.21249258"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jca.22027","article-title":"Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster-randomized controlled trial","volume":"38","author":"Luo","year":"2023","journal-title":"J. Clin. Apher."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ayg\u00fcn, F., Varol, F., Durak, C., Talip Petmezci, M., Kacar, A., Dursun, H., Irdem, A., \u00c7oku\u011fra\u015f, H., Camc\u0131o\u011flu, Y., and \u00c7am, H. (2019). Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children. Medicina, 55.","DOI":"10.3390\/medicina55070350"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/CRD.0000000000000330","article-title":"Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis","volume":"28","author":"Shah","year":"2020","journal-title":"Cardiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sabaka, P., Ko\u0161\u010d\u00e1lov\u00e1, A., Straka, I., Hodosy, J., Lipt\u00e1k, R., Kmotorkov\u00e1, B., Kachl\u00edkov\u00e1, M., and Ku\u0161n\u00edrov\u00e1, A. (2021). Role of interleukin 6 as a predictive factor for a severe course of COVID-19: Retrospective data analysis of patients from a long-term care facility during COVID-19 outbreak. BMC Infect Dis., 21.","DOI":"10.1186\/s12879-021-05945-8"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"REMAP-CAP Investigators, Gordon, A.C., Mouncey, P.R., Al-Beidh, F., Rowan, K.M., Nichol, A.D., Arabi, Y.M., Annane, D., Beane, A., and van Bentum-Puijk, W. (2021). Interleukin-6 Receptor Antagonists in Critically Ill Patients with COVID-19. N. Engl. J. Med., 384, 1491\u20131502.","DOI":"10.1056\/NEJMoa2100433"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2020.06.064","article-title":"Therapeutic plasma exchange in adults with severe COVID-19 infection","volume":"99","author":"Khamis","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16876","DOI":"10.1038\/s41598-024-67028-3","article-title":"A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX)","volume":"14","author":"Arulkumaran","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"106334","DOI":"10.1016\/j.ijantimicag.2021.106334","article-title":"Therapeutic plasma exchange in patients with life-threatening COVID-19: A randomised controlled clinical trial","volume":"57","author":"Faqihi","year":"2021","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.chest.2020.11.049","article-title":"Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients","volume":"159","author":"Dupont","year":"2021","journal-title":"Chest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2217\/bmm-2021-0341","article-title":"Prognostic value of D-dimer\/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19","volume":"15","author":"Murat","year":"2021","journal-title":"Biomark. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, X., Liu, J., Deng, X., and Bo, L. (2024). Understanding COVID-19-associated endothelial dysfunction: Role of PIEZO1 as a potential therapeutic target. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1281263"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10456-020-09730-0","article-title":"Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients","volume":"23","author":"Smadja","year":"2020","journal-title":"Angiogenesis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1038\/s41598-022-08853-2","article-title":"Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients","volume":"12","author":"Seibert","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","article-title":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: A retrospective study","volume":"24","author":"Gucyetmez","year":"2020","journal-title":"Crit. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"106669","DOI":"10.1016\/j.rmed.2021.106669","article-title":"Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases","volume":"189","author":"Hassaniazad","year":"2021","journal-title":"Respir. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41598-022-25930-8","article-title":"Impact of plasmapheresis on severe COVID-19","volume":"13","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Huang","year":"2020","journal-title":"Nat. Med."},{"key":"ref_24","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Shankar-Hari, M., Vale, C.L., Godolphin, P.J., Fisher, D., Higgins, J.P.T., Spiga, F., Savovic, J., Tierney, J., and Baron, G. (2021). Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA, 326, 499\u2013518."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00010","DOI":"10.1097\/JTCCM-D-23-00010","article-title":"Therapeutic plasma exchange in critical illness","volume":"5","author":"Koniman","year":"2023","journal-title":"J. Transl. Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40635-023-00510-w","article-title":"Research priorities for therapeutic plasma exchange in critically ill patients","volume":"11","author":"David","year":"2023","journal-title":"Intensive Care Med. Exp."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tapalaga, G., Stanga, L., and S\u00eerbu, I. (2025). Systematic Review of Lead Exposure and Its Effects on Caries and Aesthetics in Children and Adolescents. Healthcare, 13.","DOI":"10.3390\/healthcare13121460"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Stanciu, I.-V., Fildan, A.-P., Thakur, B.R., Ilie, A.C., Stanga, L., Oancea, C., Tudorache, E., Bratosin, F., Rosca, O., and Bogdan, I. (2025). Full-Blood Inflammatory Ratios Predict Length of Stay but Not Early Death in Romanian Pulmonary Tuberculosis. Medicina, 61.","DOI":"10.3390\/medicina61071238"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Nistor, P., Stanga, L., Chirila, A., Iorgoni, V., Gligor, A., Ciresan, A., Popa, I., Florea, B., Imre, M., and Cocioba, V. (2025). Seroprevalence and Passive Clinical Surveillance of West Nile Virus in Horses from Ecological High-Risk Areas in Western Romania: Exploratory Findings from a Cross-Sectional Study. Microorganisms, 13.","DOI":"10.3390\/microorganisms13081910"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Betea, R., Budisan, C., Stanga, L., Muresan, M.C., Popa, Z.L., Citu, C., Ratiu, A., and Chiriac, V.D. (2025). Quality-of-Life Trajectories and Perceived Stress in Women Treated for Uterine Cancer: A Six-Month Prospective Study. Healthcare, 13.","DOI":"10.3390\/healthcare13151787"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Stanciu, I.-V., Fildan, A.-P., Chenna, V.S.H., Ilie, A.C., Tudorache, E., Rosca, O., Stanga, L., Cozma, G.V., Preotesoiu, I., and Dantes, E. (2025). Physiologic-Inflammatory-Nutrition (TRIAD-TB) Score at 72 Hours Predicts 30-Day Mortality and Length of Stay in Pulmonary Tuberculosis: A Prospective Cohort Study. Biomedicines, 13.","DOI":"10.3390\/biomedicines13122901"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Iorgoni, V., Stanga, L., Iancu, I., Degi, J., Popa, I., Gligor, A., Orghici, G., Sicoe, B., Dreghiciu, I.C., and Purec, D. (2025). Multidrug-Resistant Escherichia coli Associated with Respiratory and Systemic Infection in a Domestic Rabbit in Romania: First Confirmed Case. Antibiotics, 14.","DOI":"10.3390\/antibiotics14090929"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Iacob, M.S., Kundnani, N.R., Sharma, A., Meche, V., Ciobotaru, P., Bedreag, O., Sandesc, D., Dragan, S.R., Papurica, M., and Stanga, L.C. (2025). Multifactorial Risk Stratification in Patients with Heart Failure, Chronic Kidney Disease, and Atrial Fibrillation: A Comprehensive Analysis. Life, 15.","DOI":"10.3390\/life15050786"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Daliu, P., Bogdan, I., Rosca, O., Licker, M., Stanga, L.C., Hogea, E., Berceanu Vaduva, D., and Muntean, D. (2025). Fungal Pulmonary Coinfections in COVID-19: Microbiological Assessment, Inflammatory Profiles, and Clinical Outcomes. Biomedicines, 13.","DOI":"10.3390\/biomedicines13040864"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/123\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:18:43Z","timestamp":1775117923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["diseases14040123"],"URL":"https:\/\/doi.org\/10.3390\/diseases14040123","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]}}}